nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP3A4—Thiotepa—urinary bladder cancer	0.0332	0.186	CbGbCtD
Mirtazapine—HTR7—vas deferens—urinary bladder cancer	0.0313	0.218	CbGeAlD
Mirtazapine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0266	0.149	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—urinary bladder cancer	0.0222	0.124	CbGbCtD
Mirtazapine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0206	0.115	CbGbCtD
Mirtazapine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0185	0.104	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—urinary bladder cancer	0.0172	0.0961	CbGbCtD
Mirtazapine—CYP2C9—Cisplatin—urinary bladder cancer	0.0157	0.0881	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00965	0.054	CbGbCtD
Mirtazapine—CYP3A4—Etoposide—urinary bladder cancer	0.009	0.0503	CbGbCtD
Mirtazapine—CYP1A2—urine—urinary bladder cancer	0.0062	0.0432	CbGeAlD
Mirtazapine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00614	0.0343	CbGbCtD
Mirtazapine—CYP2C9—urine—urinary bladder cancer	0.00589	0.041	CbGeAlD
Mirtazapine—OPRK1—prostate gland—urinary bladder cancer	0.00556	0.0387	CbGeAlD
Mirtazapine—HTR2A—urine—urinary bladder cancer	0.00485	0.0338	CbGeAlD
Mirtazapine—CYP3A4—urine—urinary bladder cancer	0.00449	0.0313	CbGeAlD
Mirtazapine—CYP2D6—urine—urinary bladder cancer	0.00442	0.0308	CbGeAlD
Mirtazapine—ADRB1—prostate gland—urinary bladder cancer	0.00341	0.0237	CbGeAlD
Mirtazapine—OPRK1—female reproductive system—urinary bladder cancer	0.00304	0.0211	CbGeAlD
Mirtazapine—ADRA1A—prostate gland—urinary bladder cancer	0.00269	0.0188	CbGeAlD
Mirtazapine—ADRA2C—prostate gland—urinary bladder cancer	0.00257	0.0179	CbGeAlD
Mirtazapine—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00231	0.0161	CbGeAlD
Mirtazapine—ADRA2C—seminal vesicle—urinary bladder cancer	0.00217	0.0151	CbGeAlD
Mirtazapine—HRH1—prostate gland—urinary bladder cancer	0.00208	0.0145	CbGeAlD
Mirtazapine—HTR7—epithelium—urinary bladder cancer	0.00205	0.0143	CbGeAlD
Mirtazapine—ADRA2A—prostate gland—urinary bladder cancer	0.00205	0.0143	CbGeAlD
Mirtazapine—HTR1A—renal system—urinary bladder cancer	0.00199	0.0139	CbGeAlD
Mirtazapine—ADRA1A—epithelium—urinary bladder cancer	0.00198	0.0138	CbGeAlD
Mirtazapine—HTR7—smooth muscle tissue—urinary bladder cancer	0.00198	0.0138	CbGeAlD
Mirtazapine—HTR7—renal system—urinary bladder cancer	0.0019	0.0133	CbGeAlD
Mirtazapine—HTR2C—female reproductive system—urinary bladder cancer	0.00189	0.0132	CbGeAlD
Mirtazapine—ADRB1—female reproductive system—urinary bladder cancer	0.00186	0.0129	CbGeAlD
Mirtazapine—ADRA1A—renal system—urinary bladder cancer	0.00184	0.0128	CbGeAlD
Mirtazapine—SLC6A4—female reproductive system—urinary bladder cancer	0.0018	0.0125	CbGeAlD
Mirtazapine—HTR2B—female reproductive system—urinary bladder cancer	0.00178	0.0124	CbGeAlD
Mirtazapine—ADRA2C—renal system—urinary bladder cancer	0.00175	0.0122	CbGeAlD
Mirtazapine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00173	0.0121	CbGeAlD
Mirtazapine—ADRA2C—urethra—urinary bladder cancer	0.00172	0.012	CbGeAlD
Mirtazapine—CYP2C8—renal system—urinary bladder cancer	0.00162	0.0113	CbGeAlD
Mirtazapine—HTR2B—vagina—urinary bladder cancer	0.00161	0.0112	CbGeAlD
Mirtazapine—SLC6A2—female reproductive system—urinary bladder cancer	0.00158	0.011	CbGeAlD
Mirtazapine—HRH1—epithelium—urinary bladder cancer	0.00153	0.0107	CbGeAlD
Mirtazapine—HTR7—female reproductive system—urinary bladder cancer	0.00152	0.0106	CbGeAlD
Mirtazapine—CYP1A2—renal system—urinary bladder cancer	0.00152	0.0106	CbGeAlD
Mirtazapine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00148	0.0103	CbGeAlD
Mirtazapine—HRH1—urethra—urinary bladder cancer	0.0014	0.00972	CbGeAlD
Mirtazapine—ADRA2A—urethra—urinary bladder cancer	0.00137	0.00955	CbGeAlD
Mirtazapine—CYP2C8—female reproductive system—urinary bladder cancer	0.0013	0.00904	CbGeAlD
Mirtazapine—HTR2A—epithelium—urinary bladder cancer	0.00128	0.00891	CbGeAlD
Mirtazapine—ADRA2C—vagina—urinary bladder cancer	0.00127	0.00882	CbGeAlD
Mirtazapine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00123	0.00858	CbGeAlD
Mirtazapine—HTR2A—renal system—urinary bladder cancer	0.00119	0.00826	CbGeAlD
Mirtazapine—CYP2C8—vagina—urinary bladder cancer	0.00117	0.00818	CbGeAlD
Mirtazapine—CYP2C9—female reproductive system—urinary bladder cancer	0.00115	0.00803	CbGeAlD
Mirtazapine—HRH1—female reproductive system—urinary bladder cancer	0.00114	0.00792	CbGeAlD
Mirtazapine—ADRA2A—female reproductive system—urinary bladder cancer	0.00112	0.00778	CbGeAlD
Mirtazapine—CYP3A4—renal system—urinary bladder cancer	0.0011	0.00765	CbGeAlD
Mirtazapine—CYP2D6—renal system—urinary bladder cancer	0.00108	0.00753	CbGeAlD
Mirtazapine—HTR2B—lymph node—urinary bladder cancer	0.00104	0.00725	CbGeAlD
Mirtazapine—HRH1—vagina—urinary bladder cancer	0.00103	0.00717	CbGeAlD
Mirtazapine—ADRA2A—vagina—urinary bladder cancer	0.00101	0.00704	CbGeAlD
Mirtazapine—HTR2A—female reproductive system—urinary bladder cancer	0.000951	0.00662	CbGeAlD
Mirtazapine—SLC6A2—lymph node—urinary bladder cancer	0.000925	0.00644	CbGeAlD
Mirtazapine—CYP3A4—female reproductive system—urinary bladder cancer	0.00088	0.00613	CbGeAlD
Mirtazapine—CYP2D6—female reproductive system—urinary bladder cancer	0.000866	0.00603	CbGeAlD
Mirtazapine—HTR2A—vagina—urinary bladder cancer	0.00086	0.00599	CbGeAlD
Mirtazapine—ADRA2C—lymph node—urinary bladder cancer	0.00082	0.00571	CbGeAlD
Mirtazapine—HRH1—lymph node—urinary bladder cancer	0.000666	0.00464	CbGeAlD
Mirtazapine—ADRA2A—lymph node—urinary bladder cancer	0.000654	0.00455	CbGeAlD
Mirtazapine—Rhinitis—Epirubicin—urinary bladder cancer	0.000251	0.000453	CcSEcCtD
Mirtazapine—Body temperature increased—Etoposide—urinary bladder cancer	0.000251	0.000453	CcSEcCtD
Mirtazapine—Abdominal pain—Etoposide—urinary bladder cancer	0.000251	0.000453	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000251	0.000453	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000251	0.000453	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—urinary bladder cancer	0.00025	0.000452	CcSEcCtD
Mirtazapine—Eye disorder—Methotrexate—urinary bladder cancer	0.00025	0.000451	CcSEcCtD
Mirtazapine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00025	0.000451	CcSEcCtD
Mirtazapine—Tinnitus—Methotrexate—urinary bladder cancer	0.000249	0.00045	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000249	0.00045	CcSEcCtD
Mirtazapine—Asthenia—Cisplatin—urinary bladder cancer	0.000248	0.000449	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000248	0.000449	CcSEcCtD
Mirtazapine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000248	0.000448	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—urinary bladder cancer	0.000247	0.000447	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000247	0.000446	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000246	0.000445	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—urinary bladder cancer	0.000246	0.000444	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000245	0.000443	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000244	0.000441	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000243	0.000439	CcSEcCtD
Mirtazapine—Angiopathy—Methotrexate—urinary bladder cancer	0.000243	0.000438	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000242	0.000437	CcSEcCtD
Mirtazapine—Dizziness—Fluorouracil—urinary bladder cancer	0.000241	0.000436	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000241	0.000435	CcSEcCtD
Mirtazapine—Chills—Methotrexate—urinary bladder cancer	0.00024	0.000433	CcSEcCtD
Mirtazapine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000237	0.000428	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000237	0.000427	CcSEcCtD
Mirtazapine—Alopecia—Methotrexate—urinary bladder cancer	0.000236	0.000427	CcSEcCtD
Mirtazapine—Vomiting—Gemcitabine—urinary bladder cancer	0.000236	0.000427	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000236	0.000426	CcSEcCtD
Mirtazapine—Mental disorder—Methotrexate—urinary bladder cancer	0.000234	0.000423	CcSEcCtD
Mirtazapine—Rash—Gemcitabine—urinary bladder cancer	0.000234	0.000423	CcSEcCtD
Mirtazapine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000234	0.000423	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—urinary bladder cancer	0.000234	0.000422	CcSEcCtD
Mirtazapine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000234	0.000422	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—urinary bladder cancer	0.000233	0.000421	CcSEcCtD
Mirtazapine—Malnutrition—Methotrexate—urinary bladder cancer	0.000233	0.00042	CcSEcCtD
Mirtazapine—Headache—Gemcitabine—urinary bladder cancer	0.000233	0.00042	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000232	0.00042	CcSEcCtD
Mirtazapine—Vomiting—Fluorouracil—urinary bladder cancer	0.000232	0.000419	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000232	0.000419	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000231	0.000418	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00023	0.000416	CcSEcCtD
Mirtazapine—Rash—Fluorouracil—urinary bladder cancer	0.00023	0.000416	CcSEcCtD
Mirtazapine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00023	0.000416	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00023	0.000415	CcSEcCtD
Mirtazapine—Headache—Fluorouracil—urinary bladder cancer	0.000229	0.000413	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000229	0.000413	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000228	0.000412	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000228	0.000412	CcSEcCtD
Mirtazapine—Asthenia—Etoposide—urinary bladder cancer	0.000227	0.000411	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—urinary bladder cancer	0.000227	0.00041	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000227	0.00041	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—urinary bladder cancer	0.000225	0.000407	CcSEcCtD
Mirtazapine—Chills—Epirubicin—urinary bladder cancer	0.000224	0.000406	CcSEcCtD
Mirtazapine—Pruritus—Etoposide—urinary bladder cancer	0.000224	0.000405	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000223	0.000404	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—urinary bladder cancer	0.000221	0.000399	CcSEcCtD
Mirtazapine—Nausea—Gemcitabine—urinary bladder cancer	0.000221	0.000399	CcSEcCtD
Mirtazapine—Vomiting—Cisplatin—urinary bladder cancer	0.00022	0.000398	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—urinary bladder cancer	0.000219	0.000396	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000219	0.000395	CcSEcCtD
Mirtazapine—Rash—Cisplatin—urinary bladder cancer	0.000218	0.000394	CcSEcCtD
Mirtazapine—Dermatitis—Cisplatin—urinary bladder cancer	0.000218	0.000394	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—urinary bladder cancer	0.000218	0.000394	CcSEcCtD
Mirtazapine—Diarrhoea—Etoposide—urinary bladder cancer	0.000217	0.000392	CcSEcCtD
Mirtazapine—Nausea—Fluorouracil—urinary bladder cancer	0.000217	0.000392	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000216	0.000391	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000216	0.00039	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000216	0.00039	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—urinary bladder cancer	0.000215	0.000389	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000215	0.000388	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—urinary bladder cancer	0.000215	0.000388	CcSEcCtD
Mirtazapine—Tension—Epirubicin—urinary bladder cancer	0.000214	0.000386	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000213	0.000385	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—urinary bladder cancer	0.000212	0.000382	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—urinary bladder cancer	0.000211	0.000381	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—urinary bladder cancer	0.00021	0.000379	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—urinary bladder cancer	0.00021	0.000379	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—urinary bladder cancer	0.00021	0.000379	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—urinary bladder cancer	0.000209	0.000378	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—urinary bladder cancer	0.000208	0.000376	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—urinary bladder cancer	0.000208	0.000375	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000207	0.000374	CcSEcCtD
Mirtazapine—Nausea—Cisplatin—urinary bladder cancer	0.000206	0.000371	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—urinary bladder cancer	0.000205	0.00037	CcSEcCtD
Mirtazapine—Cough—Methotrexate—urinary bladder cancer	0.000203	0.000367	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000203	0.000366	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000202	0.000365	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—urinary bladder cancer	0.000202	0.000364	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—urinary bladder cancer	0.000202	0.000364	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000202	0.000364	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—urinary bladder cancer	0.000201	0.000364	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—urinary bladder cancer	0.0002	0.000362	CcSEcCtD
Mirtazapine—Rash—Etoposide—urinary bladder cancer	0.0002	0.000361	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—urinary bladder cancer	0.0002	0.000361	CcSEcCtD
Mirtazapine—Headache—Etoposide—urinary bladder cancer	0.000199	0.000359	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—urinary bladder cancer	0.000199	0.000359	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—urinary bladder cancer	0.000198	0.000358	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—urinary bladder cancer	0.000198	0.000358	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—urinary bladder cancer	0.000198	0.000358	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—urinary bladder cancer	0.000198	0.000357	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000197	0.000357	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000197	0.000356	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—urinary bladder cancer	0.000196	0.000355	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—urinary bladder cancer	0.000196	0.000354	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—urinary bladder cancer	0.000196	0.000354	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—urinary bladder cancer	0.000196	0.000354	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—urinary bladder cancer	0.000195	0.000353	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—urinary bladder cancer	0.000195	0.000352	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—urinary bladder cancer	0.000195	0.000352	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—urinary bladder cancer	0.000192	0.000348	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—urinary bladder cancer	0.000192	0.000346	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000191	0.000346	CcSEcCtD
Mirtazapine—Cough—Epirubicin—urinary bladder cancer	0.00019	0.000343	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—urinary bladder cancer	0.000189	0.000341	CcSEcCtD
Mirtazapine—Infection—Methotrexate—urinary bladder cancer	0.000189	0.000341	CcSEcCtD
Mirtazapine—Nausea—Etoposide—urinary bladder cancer	0.000188	0.00034	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—urinary bladder cancer	0.000188	0.00034	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000187	0.000338	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000186	0.000337	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—urinary bladder cancer	0.000186	0.000337	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000186	0.000336	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—urinary bladder cancer	0.000185	0.000335	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—urinary bladder cancer	0.000185	0.000335	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—urinary bladder cancer	0.000185	0.000335	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—urinary bladder cancer	0.000185	0.000335	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—urinary bladder cancer	0.000185	0.000334	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—urinary bladder cancer	0.000184	0.000333	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000184	0.000333	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000184	0.000332	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—urinary bladder cancer	0.000183	0.000331	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—urinary bladder cancer	0.000182	0.000328	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—urinary bladder cancer	0.000181	0.000328	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—urinary bladder cancer	0.000181	0.000327	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—urinary bladder cancer	0.000181	0.000327	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—urinary bladder cancer	0.000181	0.000327	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—urinary bladder cancer	0.00018	0.000326	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—urinary bladder cancer	0.000179	0.000324	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—urinary bladder cancer	0.000178	0.000322	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—urinary bladder cancer	0.000178	0.000321	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—urinary bladder cancer	0.000177	0.000321	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000177	0.00032	CcSEcCtD
Mirtazapine—Infection—Epirubicin—urinary bladder cancer	0.000177	0.000319	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—urinary bladder cancer	0.000176	0.000318	CcSEcCtD
Mirtazapine—Shock—Epirubicin—urinary bladder cancer	0.000175	0.000316	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—urinary bladder cancer	0.000175	0.000315	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000174	0.000315	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000174	0.000314	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—urinary bladder cancer	0.000174	0.000314	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—urinary bladder cancer	0.000173	0.000313	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000173	0.000313	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—urinary bladder cancer	0.000173	0.000312	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000172	0.00031	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—urinary bladder cancer	0.000172	0.00031	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—urinary bladder cancer	0.000172	0.00031	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—urinary bladder cancer	0.000172	0.00031	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000172	0.00031	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—urinary bladder cancer	0.000171	0.000309	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000171	0.000308	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00017	0.000308	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—urinary bladder cancer	0.00017	0.000306	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—urinary bladder cancer	0.000169	0.000306	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000169	0.000306	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—urinary bladder cancer	0.000169	0.000305	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000168	0.000303	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000167	0.000302	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—urinary bladder cancer	0.000166	0.0003	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—urinary bladder cancer	0.000166	0.0003	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000165	0.000298	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—urinary bladder cancer	0.000164	0.000297	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000164	0.000296	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—urinary bladder cancer	0.000164	0.000296	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—urinary bladder cancer	0.000163	0.000295	CcSEcCtD
Mirtazapine—Pain—Methotrexate—urinary bladder cancer	0.000162	0.000293	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000162	0.000293	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—urinary bladder cancer	0.000162	0.000292	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000161	0.000291	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000161	0.000291	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—urinary bladder cancer	0.000161	0.00029	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000161	0.00029	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000289	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—urinary bladder cancer	0.00016	0.000288	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000159	0.000287	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000158	0.000286	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—urinary bladder cancer	0.000158	0.000286	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—urinary bladder cancer	0.000157	0.000283	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000157	0.000283	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000156	0.000283	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000155	0.000281	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000155	0.000279	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—urinary bladder cancer	0.000154	0.000278	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000153	0.000277	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—urinary bladder cancer	0.000153	0.000277	CcSEcCtD
Mirtazapine—Pain—Epirubicin—urinary bladder cancer	0.000152	0.000275	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—urinary bladder cancer	0.000152	0.000275	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—urinary bladder cancer	0.000151	0.000273	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—urinary bladder cancer	0.00015	0.000271	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—urinary bladder cancer	0.00015	0.000271	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00015	0.000271	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—urinary bladder cancer	0.000149	0.000269	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000148	0.000267	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000147	0.000265	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000146	0.000265	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—urinary bladder cancer	0.000146	0.000264	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000145	0.000263	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000145	0.000262	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000143	0.000258	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000142	0.000257	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—urinary bladder cancer	0.000142	0.000256	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—urinary bladder cancer	0.000141	0.000255	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—urinary bladder cancer	0.000141	0.000254	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—urinary bladder cancer	0.000141	0.000254	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000141	0.000254	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000141	0.000254	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00014	0.000253	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—urinary bladder cancer	0.000136	0.000246	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000136	0.000245	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000134	0.000243	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—urinary bladder cancer	0.000134	0.000243	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000131	0.000237	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—urinary bladder cancer	0.000131	0.000236	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00013	0.000235	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00013	0.000235	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—urinary bladder cancer	0.00013	0.000235	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—urinary bladder cancer	0.000128	0.00023	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—urinary bladder cancer	0.000126	0.000227	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—urinary bladder cancer	0.000126	0.000227	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000122	0.00022	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000121	0.000219	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—urinary bladder cancer	0.000121	0.000218	CcSEcCtD
Mirtazapine—Rash—Methotrexate—urinary bladder cancer	0.00012	0.000216	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—urinary bladder cancer	0.00012	0.000216	CcSEcCtD
Mirtazapine—Headache—Methotrexate—urinary bladder cancer	0.000119	0.000215	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—urinary bladder cancer	0.000118	0.000213	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—urinary bladder cancer	0.000118	0.000212	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—urinary bladder cancer	0.000116	0.00021	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—urinary bladder cancer	0.000113	0.000204	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—urinary bladder cancer	0.000113	0.000204	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000113	0.000203	CcSEcCtD
Mirtazapine—Rash—Epirubicin—urinary bladder cancer	0.000112	0.000202	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—urinary bladder cancer	0.000112	0.000202	CcSEcCtD
Mirtazapine—Headache—Epirubicin—urinary bladder cancer	0.000111	0.000201	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—urinary bladder cancer	0.000109	0.000197	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—urinary bladder cancer	0.000106	0.000191	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—urinary bladder cancer	0.000105	0.000189	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—urinary bladder cancer	0.000104	0.000187	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000104	0.000187	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—urinary bladder cancer	0.000103	0.000186	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—urinary bladder cancer	9.77e-05	0.000177	CcSEcCtD
Mirtazapine—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	1.28e-05	0.000103	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	1.28e-05	0.000103	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CREBBP—urinary bladder cancer	1.27e-05	0.000103	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.27e-05	0.000103	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EP300—urinary bladder cancer	1.27e-05	0.000102	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	1.26e-05	0.000102	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.26e-05	0.000102	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IGF1—urinary bladder cancer	1.26e-05	0.000101	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ERBB2—urinary bladder cancer	1.26e-05	0.000101	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.25e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—EGFR—urinary bladder cancer	1.25e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL8—urinary bladder cancer	1.25e-05	0.000101	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTEN—urinary bladder cancer	1.25e-05	0.0001	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HRAS—urinary bladder cancer	1.24e-05	0.0001	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MMP9—urinary bladder cancer	1.24e-05	0.0001	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.24e-05	9.97e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.24e-05	9.96e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PTEN—urinary bladder cancer	1.24e-05	9.95e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—SRC—urinary bladder cancer	1.23e-05	9.92e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	1.23e-05	9.9e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	1.23e-05	9.88e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL8—urinary bladder cancer	1.22e-05	9.86e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ERBB2—urinary bladder cancer	1.22e-05	9.84e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HRAS—urinary bladder cancer	1.22e-05	9.8e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	1.21e-05	9.74e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MYC—urinary bladder cancer	1.21e-05	9.72e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	1.21e-05	9.72e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	1.2e-05	9.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	1.2e-05	9.64e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	1.2e-05	9.64e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.2e-05	9.63e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—urinary bladder cancer	1.2e-05	9.63e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL8—urinary bladder cancer	1.19e-05	9.59e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	1.19e-05	9.58e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—EP300—urinary bladder cancer	1.19e-05	9.57e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.19e-05	9.55e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	1.18e-05	9.54e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	1.18e-05	9.53e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HRAS—urinary bladder cancer	1.18e-05	9.53e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EGFR—urinary bladder cancer	1.18e-05	9.51e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	1.18e-05	9.49e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EP300—urinary bladder cancer	1.18e-05	9.49e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	1.18e-05	9.47e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.17e-05	9.46e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.17e-05	9.43e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—urinary bladder cancer	1.17e-05	9.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	1.17e-05	9.42e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCND1—urinary bladder cancer	1.17e-05	9.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	1.16e-05	9.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	1.16e-05	9.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL8—urinary bladder cancer	1.16e-05	9.33e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MYC—urinary bladder cancer	1.16e-05	9.31e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	1.15e-05	9.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HRAS—urinary bladder cancer	1.15e-05	9.27e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.15e-05	9.26e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—SRC—urinary bladder cancer	1.15e-05	9.23e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	1.14e-05	9.22e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.14e-05	9.21e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCND1—urinary bladder cancer	1.14e-05	9.19e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	1.14e-05	9.17e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.14e-05	9.15e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.14e-05	9.15e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	1.13e-05	9.13e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—urinary bladder cancer	1.13e-05	9.12e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—urinary bladder cancer	1.13e-05	9.1e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.13e-05	9.09e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PTEN—urinary bladder cancer	1.13e-05	9.06e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.12e-05	9.06e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KRAS—urinary bladder cancer	1.12e-05	8.98e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	1.12e-05	8.98e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	1.11e-05	8.94e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	1.11e-05	8.93e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—urinary bladder cancer	1.11e-05	8.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—urinary bladder cancer	1.11e-05	8.92e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.1e-05	8.89e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MYC—urinary bladder cancer	1.1e-05	8.89e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PTEN—urinary bladder cancer	1.1e-05	8.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	1.1e-05	8.86e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	1.09e-05	8.78e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	1.09e-05	8.77e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.09e-05	8.76e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	1.08e-05	8.72e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCND1—urinary bladder cancer	1.08e-05	8.69e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—urinary bladder cancer	1.08e-05	8.69e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.08e-05	8.69e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	1.08e-05	8.68e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	1.08e-05	8.67e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	1.07e-05	8.65e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EP300—urinary bladder cancer	1.07e-05	8.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	1.07e-05	8.63e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	1.07e-05	8.63e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	8.6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	1.07e-05	8.6e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—urinary bladder cancer	1.07e-05	8.6e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	1.05e-05	8.47e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EP300—urinary bladder cancer	1.05e-05	8.46e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—urinary bladder cancer	1.05e-05	8.44e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	1.04e-05	8.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CDKN1A—urinary bladder cancer	1.04e-05	8.41e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SRC—urinary bladder cancer	1.04e-05	8.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTEN—urinary bladder cancer	1.04e-05	8.39e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	1.03e-05	8.33e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	1.03e-05	8.31e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	1.03e-05	8.28e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	1.03e-05	8.27e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—urinary bladder cancer	1.03e-05	8.27e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	1.03e-05	8.26e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	1.02e-05	8.23e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SRC—urinary bladder cancer	1.02e-05	8.22e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—urinary bladder cancer	1.02e-05	8.21e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	1.01e-05	8.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	1.01e-05	8.15e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	1.01e-05	8.11e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	1.01e-05	8.1e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	1e-05	8.09e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1e-05	8.09e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	1e-05	8.09e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	9.98e-06	8.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EP300—urinary bladder cancer	9.93e-06	8e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	9.93e-06	8e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	9.92e-06	7.99e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—urinary bladder cancer	9.91e-06	7.99e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	9.88e-06	7.96e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	9.86e-06	7.94e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	9.79e-06	7.89e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	9.68e-06	7.8e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SRC—urinary bladder cancer	9.66e-06	7.78e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—EP300—urinary bladder cancer	9.65e-06	7.77e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	9.63e-06	7.76e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	9.63e-06	7.76e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	9.61e-06	7.74e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	9.61e-06	7.74e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.54e-06	7.69e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	9.53e-06	7.67e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	9.51e-06	7.66e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—urinary bladder cancer	9.49e-06	7.64e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	9.48e-06	7.64e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—urinary bladder cancer	9.48e-06	7.64e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	9.47e-06	7.63e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	9.45e-06	7.61e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	9.43e-06	7.6e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	9.41e-06	7.58e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	9.35e-06	7.53e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—urinary bladder cancer	9.35e-06	7.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	9.35e-06	7.53e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	9.33e-06	7.52e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	9.32e-06	7.51e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	9.3e-06	7.49e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	9.3e-06	7.49e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	9.28e-06	7.47e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	9.23e-06	7.44e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	9.21e-06	7.42e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	9.16e-06	7.38e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.15e-06	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—urinary bladder cancer	9.15e-06	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—urinary bladder cancer	9.15e-06	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	9.13e-06	7.35e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	9.1e-06	7.33e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—urinary bladder cancer	9.07e-06	7.31e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—urinary bladder cancer	9.06e-06	7.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	9.01e-06	7.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	8.99e-06	7.24e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—urinary bladder cancer	8.95e-06	7.21e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	8.94e-06	7.21e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	8.9e-06	7.17e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.87e-06	7.14e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	8.87e-06	7.14e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	8.85e-06	7.13e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.77e-06	7.06e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.77e-06	7.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	8.76e-06	7.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	8.76e-06	7.06e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	8.75e-06	7.05e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	8.7e-06	7.01e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	8.68e-06	6.99e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—urinary bladder cancer	8.66e-06	6.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—urinary bladder cancer	8.66e-06	6.97e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—urinary bladder cancer	8.64e-06	6.96e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	8.62e-06	6.95e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	8.6e-06	6.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	8.51e-06	6.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.48e-06	6.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—urinary bladder cancer	8.47e-06	6.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	8.46e-06	6.81e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—urinary bladder cancer	8.45e-06	6.81e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	8.44e-06	6.8e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—urinary bladder cancer	8.43e-06	6.79e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.4e-06	6.76e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	8.26e-06	6.66e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.24e-06	6.64e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	8.22e-06	6.62e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.14e-06	6.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	8.07e-06	6.5e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	8.06e-06	6.49e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	8.03e-06	6.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—urinary bladder cancer	8e-06	6.44e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	7.85e-06	6.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	7.85e-06	6.32e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	7.82e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.75e-06	6.24e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	7.73e-06	6.23e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	7.71e-06	6.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	7.68e-06	6.19e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—urinary bladder cancer	7.68e-06	6.19e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—EP300—urinary bladder cancer	7.66e-06	6.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	7.57e-06	6.1e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.56e-06	6.09e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	7.56e-06	6.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	7.54e-06	6.08e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—urinary bladder cancer	7.51e-06	6.05e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.49e-06	6.04e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	7.4e-06	5.96e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	7.35e-06	5.92e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—urinary bladder cancer	7.34e-06	5.92e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	7.31e-06	5.89e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	7.26e-06	5.85e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—urinary bladder cancer	7.18e-06	5.79e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	7.14e-06	5.75e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	7.12e-06	5.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—urinary bladder cancer	7.11e-06	5.73e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	7.03e-06	5.66e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	7.03e-06	5.66e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	6.99e-06	5.63e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	6.99e-06	5.63e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	6.88e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—urinary bladder cancer	6.8e-06	5.48e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.59e-06	5.31e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.54e-06	5.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	6.5e-06	5.23e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	6.45e-06	5.2e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.4e-06	5.16e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	6.35e-06	5.11e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	6.33e-06	5.1e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.29e-06	5.06e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.28e-06	5.06e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.23e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	6.21e-06	5.01e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	6.17e-06	4.97e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	6.07e-06	4.89e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	6.06e-06	4.88e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.04e-06	4.86e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	5.94e-06	4.79e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	5.77e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.58e-06	4.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	5.52e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.33e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.94e-06	3.98e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.31e-06	3.47e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.11e-06	3.31e-05	CbGpPWpGaD
